Moleculera Labs
- Diagnostics
Raising $22MM Series B for the addition of a commercial sales team, the launch of two new products in autoimmune cardiovascular and Long-COVID. Seeing partners for Tx target ID programs, and big data projects with over 15,000+ specimen biorepository.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}